Circulating Tumor DNA as a Liquid Biopsy for Glioma Detection in Cerebrospinal Fluid and Plasma: A Systematic Review and Meta-Analysis
Accurate molecular characterization of gliomas is essential for determining prognosis and guiding therapeutic decisions. In recent years, liquid biopsy for analysis of circulating tumor DNA (ctDNA) in blood or cerebrospinal fluid (CSF) has emerged as a promising, minimally invasive alternative. This study evaluat...